J&J Keeps Cheap Risperdal Off Shelves
In a win for Johnson & Johnson, a U.S. appeals court has upheld a ban on the sale of a cheap version of the pharmaceutical giant's antipsychotic drug Risperdal for the...To view the full article, register now.
Already a subscriber? Click here to view full article